879648-22-3 Usage
Uses
Used in Organic Synthesis:
4,4,5,5-Tetramethyl-2-(2-(methylsulfonyl)phenyl)-1,3,2-dioxaborolane is used as a building block for the synthesis of complex organic compounds, particularly in the creation of pharmaceuticals and biologically active molecules. Its stability and compatibility with sensitive functional groups make it a valuable tool in organic synthesis.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 4,4,5,5-Tetramethyl-2-(2-(methylsulfonyl)phenyl)-1,3,2-dioxaborolane is used as a key intermediate in the development of new drugs and therapeutic agents. Its unique properties allow for the formation of carbon-carbon bonds, facilitating the synthesis of novel and potent bioactive molecules.
Used in the Suzuki-Miyaura Coupling Reaction:
4,4,5,5-Tetramethyl-2-(2-(methylsulfonyl)phenyl)-1,3,2-dioxaborolane is employed as a reagent in the Suzuki-Miyaura coupling reaction, a widely used method for forming carbon-carbon bonds. This reaction is particularly important in the synthesis of pharmaceuticals and biologically active molecules, where the formation of specific carbon-carbon bonds is crucial for the biological activity of the final product.
Used in Electronics and Material Science:
4,4,5,5-Tetramethyl-2-(2-(methylsulfonyl)phenyl)-1,3,2-dioxaborolane may also be used in the development of materials for applications in electronics and material science. Its unique chemical properties and reactivity make it a promising candidate for the creation of new materials with specific electronic or material properties.
Check Digit Verification of cas no
The CAS Registry Mumber 879648-22-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,9,6,4 and 8 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 879648-22:
(8*8)+(7*7)+(6*9)+(5*6)+(4*4)+(3*8)+(2*2)+(1*2)=243
243 % 10 = 3
So 879648-22-3 is a valid CAS Registry Number.
879648-22-3Relevant academic research and scientific papers
NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
-
Paragraph 0802; 0803, (2016/07/27)
The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
-
Page/Page column 282; 283, (2015/07/15)
The present invention is directed to tricyclic compounds (I), pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
